CompletedPhase 2NCT00005938

DX-8951f in Treating Patients With Biliary Cancer

Studying Adenocarcinoma of the gallbladder and extrahepatic biliary tract

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Daiichi Sankyo
Principal Investigator
Robert L. DeJager, MD, FACP
Daiichi Sankyo
Intervention
exatecan mesylate(drug)
Eligibility
16 years · All sexes
Timeline
20002005

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00005938 on ClinicalTrials.gov

Other trials for Adenocarcinoma of the gallbladder and extrahepatic biliary tract

Additional recruiting or active studies for the same condition.

See all trials for Adenocarcinoma of the gallbladder and extrahepatic biliary tract

← Back to all trials